Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 13, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, August 12, 2021
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sarah James Initiated (ACHC) at Sell and Held Target at $69 on, Aug 12th, 2021
Sarah James of Barclays, Initiated "Acadia Healthcare Company, Inc." (ACHC) at Sell and Held Target at $69 on, Aug 12th, 2021.
Sarah has made no other calls on ACHC in the last 4 months.
There are 3 other peers that have a rating on ACHC. Out of the 3 peers that are also analyzing ACHC, 2 agree with Sarah's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- A.J. Rice of "Credit Suisse" Maintained at Hold with Increased Target to $68 on, Wednesday, August 4th, 2021
- Joseph France of "Seaport Global" Initiated at Hold on, Friday, July 9th, 2021
This is the rating of the analyst that currently disagrees with Sarah
- John Ransom of "Raymond James" Maintained at Strong Buy with Increased Target to $70 on, Monday, May 3rd, 2021
